Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422848-20-000044
Filing Date
2020-02-14
Accepted
2020-02-14 12:03:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A edggild.txt SC 13G/A 6655
  Complete submission text file 0001422848-20-000044.txt   8160
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Subject) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42340 | Film No.: 20616420
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A